Jin-Ji Yang

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 7

Top Venues

Thoracic cancer

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

BMC cancer

Genes, chromosomes & cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Hai-Yan Tu, Kai Yin, Xiaotian Zhao, E-E Ke, Si-Pei Wu, Yang-Si Li, Mei-Mei Zheng, Si-Yang Maggie Liu, Chong-Rui Xu, Yue-Li Sun, Jia-Xin Lin, Xiao-Yan Bai, Yi-Chen Zhang, Qing Zhou, Jin-Ji Yang, Wen-Zhao Zhong, Bing-Chao Wang, Xu-Chao Zhang, Dongqin Zhu, Lingling Yang, Qiuxiang Ou, Yi-Long Wu
Genomic and immune characteristics of HER2-mutated non-small cell lung cancer and response to immune checkpoint inhibitor-based therapy. Molecular oncology (2023)
Hui-Bo Feng, Yu Chen, Zhi Xie, Jie Jiang, Yu-Min Zhong, Wei-Bang Guo, Wen-Qing Yan, Zhi-Yi Lv, Dan-Xia Lu, Hong-Ling Liang, Fang-Ping Xu, Jin-Ji Yang, Xue-Ning Yang, Qing Zhou, Dong-Kun Zhang, Zhou Zhang, Shao-Kun Chuai, Heng-Hui Zhang, Yi-Long Wu, Xu Chao Zhang
High SHP2 expression determines the efficacy of PD-1/PD-L1 inhibitors in advanced KRAS mutant non-small cell lung cancer. Thoracic cancer 12 (19) (2021)
Jin Kang, Qiu-Mei Deng, Kai-Cheng Peng, Peng Li, Bao-Ting Zhu, Pan Wang, Xiang-Peng Chu, Wen-Zhao Zhong, Hua-Jun Chen, Wen-Xian Wang, Hua-Fei Chen, Chuang-Zhou Rao, Chun-Wei Xu, Jin-Ji Yang
Clinicopathological features and resistance mechanisms in HIP1-ALK-rearranged lung cancer: A multicenter study. Genes, chromosomes & cancer (2021)
Xue-Wu Wei, Xin Gao, Xu Chao Zhang, Jin-Ji Yang, Zhi-Hong Chen, Yi-Long Wu, Qing Zhou
Mutational landscape and characteristics of ERBB2 in non-small cell lung cancer. Thoracic cancer 11 (6) (2020)
Wen-Zhao Zhong, Qun Wang, Wei-Min Mao, Song-Tao Xu, Lin Wu, Yu-Cheng Wei, Yong-Yu Liu, Chun Chen, Ying Cheng, Rong Yin, Fan Yang, Sheng-Xiang Ren, Xiao-Fei Li, Jian Li, Cheng Huang, Zhi-Dong Liu, Shun Xu, Ke-Neng Chen, Shi-Dong Xu, Lun-Xu Liu, Ping Yu, Bu-Hai Wang, Hai-Tao Ma, Jin-Ji Yang, Hong-Hong Yan, Xue-Ning Yang, Si-Yang Liu, Qing Zhou, Yi-Long Wu
Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (7) (2020)
Rui-Lian Chen, Jun Zhao, Xu-Chao Zhang, Na-Na Lou, Hua-Jun Chen, Xue Yang, Jian Su, Zhi Xie, Qing Zhou, Hai-Yan Tu, Wen-Zhao Zhong, Hong-Hong Yan, Wei-Bang Guo, Yi-Long Wu, Jin-Ji Yang
Crizotinib in advanced non-small-cell lung cancer with concomitant ALK rearrangement and c-Met overexpression. BMC cancer 18 (1) (2018)
Jin Kang, Hua-Jun Chen, Xu-Chao Zhang, Jian Su, Qing Zhou, Hai-Yan Tu, Zhen Wang, Bin-Chao Wang, Wen-Zhao Zhong, Xue-Ning Yang, Zhi-Hong Chen, Yan Ding, Xue Wu, Mei Wang, Jian-Gang Fu, Zhenfan Yang, Xian Zhang, Yang W Shao, Yi-Long Wu, Jin-Ji Yang
Heterogeneous responses and resistant mechanisms to crizotinib in ALK-positive advanced non-small cell lung cancer. Thoracic cancer 9 (9) (2018)

Jin-Ji Yang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jin-Ji Yang